{"id":"https://openalex.org/W3000319140","doi":"https://doi.org/10.3390/cancers12010201","title":"Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target","display_name":"Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target","publication_year":2020,"publication_date":"2020-01-14","ids":{"openalex":"https://openalex.org/W3000319140","doi":"https://doi.org/10.3390/cancers12010201","mag":"3000319140","pmid":"https://pubmed.ncbi.nlm.nih.gov/31947537","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7016952"},"language":"en","primary_location":{"id":"doi:10.3390/cancers12010201","doi":"https://doi.org/10.3390/cancers12010201","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12010201","pdf_url":"https://www.mdpi.com/2072-6694/12/1/201/pdf?version=1579670114","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2072-6694/12/1/201/pdf?version=1579670114","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090829768","display_name":"Krzysztof Brzezinka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Krzysztof Brzezinka","raw_affiliation_strings":["Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029670475","display_name":"Ekaterina Nevedomskaya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ekaterina Nevedomskaya","raw_affiliation_strings":["Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009242861","display_name":"Ralf Lesche","orcid":"https://orcid.org/0000-0003-2953-9352","observed_orcids":["https://orcid.org/0000-0003-2953-9352"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ralf Lesche","raw_affiliation_strings":["Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020529398","display_name":"Andrea Haegebarth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andrea Haegebarth","raw_affiliation_strings":["Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038269097","display_name":"Antonius ter Laak","orcid":"https://orcid.org/0000-0003-1820-002X","observed_orcids":["https://orcid.org/0000-0003-1820-002X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Antonius ter Laak","raw_affiliation_strings":["Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0003-1820-002X","affiliations":[{"raw_affiliation_string":"Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073508039","display_name":"Amaury E. Fern\u00e1ndez\u2010Montalv\u00e1n","orcid":"https://orcid.org/0000-0001-9156-0000","observed_orcids":["https://orcid.org/0000-0001-9156-0000"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Amaury E. Fern\u00e1ndez-Montalv\u00e1n","raw_affiliation_strings":["Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0001-9156-0000","affiliations":[{"raw_affiliation_string":"Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010319500","display_name":"Uwe Eberspaecher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Uwe Eberspaecher","raw_affiliation_strings":["Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081273360","display_name":"Nicolas D. Werbeck","orcid":"https://orcid.org/0000-0001-6119-031X","observed_orcids":["https://orcid.org/0000-0001-6119-031X"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nicolas D. Werbeck","raw_affiliation_strings":["Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065917119","display_name":"Ursula Moenning","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ursula Moenning","raw_affiliation_strings":["Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102918747","display_name":"Stephan Siegel","orcid":"https://orcid.org/0000-0002-4913-1146","observed_orcids":["https://orcid.org/0000-0002-4913-1146"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stephan Siegel","raw_affiliation_strings":["Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048300451","display_name":"Bernard Haendler","orcid":"https://orcid.org/0000-0002-4490-0663","observed_orcids":["https://orcid.org/0000-0002-4490-0663"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bernard Haendler","raw_affiliation_strings":["Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0002-4490-0663","affiliations":[{"raw_affiliation_string":"Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061973032","display_name":"Ashley L. Eheim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ashley L. Eheim","raw_affiliation_strings":["Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer AG, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007802195","display_name":"Carlo Stresemann","orcid":"https://orcid.org/0000-0002-1147-0927","observed_orcids":["https://orcid.org/0000-0002-1147-0927"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Carlo Stresemann","raw_affiliation_strings":["Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany"],"raw_orcid":"https://orcid.org/0000-0002-1147-0927","affiliations":[{"raw_affiliation_string":"Bayer AG, Innovation Campus Berlin, Research & Development, Pharmaceuticals, Muellerstrasse 178, D-13353 Berlin, Germany","institution_ids":["https://openalex.org/I67348948"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5007802195"],"corresponding_institution_ids":["https://openalex.org/I67348948"],"apc_list":{"value":2200,"currency":"CHF","value_usd":2324},"apc_paid":{"value":2200,"currency":"CHF","value_usd":2324},"fwci":2.001,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.87348705,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"12","issue":"1","first_page":"201","last_page":"201"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.5238999724388123,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.5238999724388123,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.36250001192092896,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.028999999165534973,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mll1","display_name":"MLL1","score":0.8349999785423279},{"id":"https://openalex.org/keywords/kmt2a","display_name":"KMT2A","score":0.9679999947547913},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8809999823570251},{"id":"https://openalex.org/keywords/gene-transcription","display_name":"gene transcription","score":0.800000011920929},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7084625959396362},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6091243624687195},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5135167241096497},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.4874839782714844},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4527384042739868},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4307781755924225},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.17416146397590637}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3390/cancers12010201","doi":"https://doi.org/10.3390/cancers12010201","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12010201","pdf_url":"https://www.mdpi.com/2072-6694/12/1/201/pdf?version=1579670114","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7016952","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7016952","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers (Basel)","raw_type":"Text"},{"id":"pmid:31947537","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31947537","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"Journal Article"},{"id":"pmh:oai:opus4.hsfu:7145","doi":null,"is_oa":true,"landing_page_url":"https://opus.hs-furtwangen.de/frontdoor/index/index/docId/7145","pdf_url":"https://opus.hs-furtwangen.de/files/7145/cancers-12-00201-v2.pdf","source":{"id":"https://openalex.org/S4377196512","display_name":"Repository of Futwangen University of Applied Sciences (Furtwangen University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I882953328","host_organization_name":"Furtwangen University","host_organization_lineage":["https://openalex.org/I882953328"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:doaj.org/article:6c52d19937c74a3093cf358c4581e2cd","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6c52d19937c74a3093cf358c4581e2cd","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancers, Vol 12, Iss 1, p 201 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/cancers12010201","doi":"https://doi.org/10.3390/cancers12010201","is_oa":true,"landing_page_url":"http://dx.doi.org/10.3390/cancers12010201","pdf_url":"https://www.mdpi.com/2072-6694/12/1/201/pdf?version=1579670114","source":{"id":"https://openalex.org/S168415115","display_name":"Cancers","issn_l":"2072-6694","issn":["2072-6694"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancers","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307771","display_name":"Bayer","ror":"https://ror.org/04hmn8g73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3000319140.pdf","grobid_xml":"https://content.openalex.org/works/W3000319140.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W1516646538","https://openalex.org/W1966727808","https://openalex.org/W1971716475","https://openalex.org/W1974222586","https://openalex.org/W1981695027","https://openalex.org/W1990739246","https://openalex.org/W1999469178","https://openalex.org/W2017446931","https://openalex.org/W2025570007","https://openalex.org/W2027275928","https://openalex.org/W2037856618","https://openalex.org/W2053964757","https://openalex.org/W2055296531","https://openalex.org/W2056283033","https://openalex.org/W2062656198","https://openalex.org/W2078404121","https://openalex.org/W2084754082","https://openalex.org/W2091376484","https://openalex.org/W2093407919","https://openalex.org/W2126917138","https://openalex.org/W2134886035","https://openalex.org/W2137876306","https://openalex.org/W2138980361","https://openalex.org/W2151718828","https://openalex.org/W2154218976","https://openalex.org/W2160614819","https://openalex.org/W2556389398","https://openalex.org/W2581909840","https://openalex.org/W2594370868","https://openalex.org/W2611381258","https://openalex.org/W2735132087","https://openalex.org/W2749384683","https://openalex.org/W2769932985","https://openalex.org/W2777307770","https://openalex.org/W2799607270","https://openalex.org/W2799870037","https://openalex.org/W2875729118","https://openalex.org/W2890448483","https://openalex.org/W2891703921","https://openalex.org/W2921841230","https://openalex.org/W2954020213"],"related_works":["https://openalex.org/W4361291437","https://openalex.org/W2151718828","https://openalex.org/W2895804881","https://openalex.org/W2006017285","https://openalex.org/W2077813339","https://openalex.org/W4237445742","https://openalex.org/W4214571245","https://openalex.org/W3211091265","https://openalex.org/W2993435749","https://openalex.org/W2741755572"],"abstract_inverted_index":{"Inhibiting":[0],"the":[1,6,47,67,71,92,95,163,170,182],"interaction":[2,73,97,165],"of":[3,49,70,78,94,119,132,139,172],"menin":[4,41],"with":[5,82],"histone":[7],"methyltransferase":[8],"MLL1":[9,38],"(KMT2A)":[10],"has":[11,185],"recently":[12],"emerged":[13],"as":[14],"a":[15,75,83,115,135,154,186],"novel":[16],"therapeutic":[17,20,117,188],"strategy.":[18],"Beneficial":[19],"effects":[21,131,196],"have":[22],"been":[23],"postulated":[24],"in":[25,31,74,106,108,122,134,148,190],"leukemia,":[26],"prostate,":[27],"breast,":[28],"liver":[29],"and":[30,85,103,158,202],"synovial":[32],"sarcoma":[33],"models.":[34,112,124,142,176],"In":[35,125,193],"those":[36],"indications,":[37],"recruitment":[39],"by":[40],"was":[42],"described":[43],"to":[44,199],"critically":[45],"regulate":[46],"expression":[48],"disease":[50],"associated":[51],"genes.":[52],"However,":[53],"most":[54,173],"findings":[55,144],"so":[56],"far":[57],"rely":[58],"on":[59],"single":[60,200],"study":[61,152],"reports.":[62],"Here":[63],"we":[64,128],"independently":[65],"evaluated":[66],"pathogenic":[68],"functions":[69],"menin-MLL":[72,96,164,183],"large":[76],"set":[77],"different":[79],"cancer":[80,175],"models":[81,201],"potent":[84,159],"selective":[86,157,187],"probe":[87],"inhibitor":[88],"BAY-155.":[89],"We":[90,113,177],"characterized":[91],"inhibition":[93],"for":[98,104,169],"anti-proliferation,":[99],"gene":[100],"transcription":[101],"effects,":[102],"efficacy":[105],"several":[107],"vivo":[109],"xenografted":[110],"tumor":[111],"found":[114],"specific":[116],"activity":[118],"BAY-155":[120,133],"primarily":[121],"AML/ALL":[123],"solid":[126,174,194],"tumors,":[127],"observed":[129],"anti-proliferative":[130],"surprisingly":[136],"limited":[137,204],"fraction":[138],"cell":[140],"line":[141],"These":[143],"were":[145],"further":[146],"validated":[147],"vivo.":[149],"Overall,":[150],"our":[151],"using":[153],"novel,":[155],"highly":[156],"inhibitor,":[160],"shows":[161],"that":[162,180],"is":[166],"not":[167],"essential":[168],"survival":[171],"can":[178],"confirm":[179],"disrupting":[181],"complex":[184],"benefit":[189],"MLL-fused":[191],"leukemia.":[192],"cancers,":[195],"are":[197],"restricted":[198],"more":[203],"than":[205],"previously":[206],"claimed.":[207]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-01-23T00:00:00"}